VACCINE - Journal - Bridge of Knowledge

Search

VACCINE

ISSN:

0264-410X

eISSN:

1873-2518

Disciplines
(Field of Science):

  • biomedical engineering (Engineering and Technology)
  • medical biology (Medical and Health Sciences )
  • pharmacology and pharmacy (Medical and Health Sciences )
  • medical sciences (Medical and Health Sciences )
  • health sciences (Medical and Health Sciences )
  • agriculture and horticulture (Agricultural sciences)
  • security studies (Social studies)
  • biotechnology (Natural sciences)
  • biological sciences (Natural sciences)

Ministry points: Help

Ministry points - current year
Year Points List
Year 2024 200 Ministry scored journals list 2024
Ministry points - previous years
Year Points List
2024 200 Ministry scored journals list 2024
2023 200 Ministry Scored Journals List
2022 100 Ministry Scored Journals List 2019-2022
2021 100 Ministry Scored Journals List 2019-2022
2020 100 Ministry Scored Journals List 2019-2022
2019 100 Ministry Scored Journals List 2019-2022
2018 30 A
2017 30 A
2016 30 A
2015 30 A
2014 30 A
2013 30 A
2012 35 A
2011 35 A
2010 32 A

Model:

Hybrid - transformation agreement

Points CiteScore:

Points CiteScore - current year
Year Points
Year 2023 8.7
Points CiteScore - previous years
Year Points
2023 8.7
2022 7.7
2021 6.7
2020 5.6
2019 5.5
2018 5.7
2017 6
2016 6.3
2015 6.6
2014 7
2013 6.7
2012 6.5
2011 6.1

Impact Factor:

Log in to see the Impact Factor.

Filters

total: 3

  • Category
  • Year

clear Chosen catalog filters disabled

Catalog Journals

Year 2018
Year 2009
Year 2007
  • GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine
    Publication
    • M. Doskaya
    • M. Kalantari-Dehaghi
    • C. M. Walsh
    • E. Hiszczyńska-Sawicka
    • H. D. Davies
    • P. L. Felgner
    • L. S. Larsen
    • R. H. Lathrop
    • W. G. Hatfield
    • J. R. Schulz... and 2 others

    - VACCINE - Year 2007

    W publikacji oszacowano immunogenność i właściwości protekcyjne szczepionki anty-Toxoplasma gondii opartej na białku rekombinantowym GRA1 oraz dwóch rodzajach szczepionek DNA (plazmidu zawierającego gen kodujący białko GRA1 dzikiego typu oraz modyfikowanego genu kodującego białko GRA1). Uzyskane wyniki sugerują lepsze właściowści immunoprotekcyjne rekombinantowego białka antygenowego niż szczepionek DNA.

    Full text to download in external service

seen 1026 times